ClinicalTrials.gov
public full text
Public Domain
Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)
The purpose of this study is to establish the safety of clevidipine in the treatment of perioperative hypertension. Approximately 250-500 patients with perioperative hypertension undergoing coronary artery bypass grafting (CABG), off-pump coronary artery bypass (OPCAB) or minimally invasive direct coronary artery bypass (MIDCAB) surgery and/or valve replacement/repair procedures were anticipated to be randomly assigned to one of two treatment groups: clevidipine or sodium nitroprusside.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF#1349495
- The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery#894674
- Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage#908677
- Antithrombotic Regimens and Outcome#1171536
- Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition#1212408
Record · ID 1365458
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive